Search
Close this search box.

Veterinarian News

USDA Actions to Protect Livestock Health From Highly Pathogenic H5N1 Avian Influenza 

Federal Order to assist with developing a baseline of critical information and limiting the spread of H5N1 in dairy cattle  WASHINGTON, April 24, 2024 – To further protect the U.S. livestock industry from the threat posed by highly pathogenic H5N1 avian influenza, USDA is sharing a number of actions...

Detection of Highly Pathogenic Avian Influenza (H5N1) in Dairy Herds: Frequently Asked Questions

This is a rapidly evolving situation and USDA, as well as state and federal partners, are committed to sharing updates as information becomes available. Here, we are answering some of the most frequently asked questions about these detections. https://www.aphis.usda.gov/sites/default/files/hpai-dairy-faqs.pdf...

April 23, 2024

Highly pathogenic avian influenza detected in TX, KS dairy cattle

(SCHAUMBURG, Illinois) March 25, 2024—Continuing their investigation into a disease event affecting primarily older dairy cows in Texas, Kansas, and New Mexico, today the U.S. Department of Agriculture (USDA), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC) announced the detection of highly pathogenic avian...

ICVA Board of Directors Call for Nominations

The ICVA has sent out a call for nominations for two at-large positions on the ICVA Board of Directors. The Board of Directors are appointed for three-year terms and may serve a maximum of three (3) terms. The ICVA holds two regular business meetings each year, typically in June...

February 6, 2024

AVMA is now accepting applications for the 2024 – 2025 AVMA Fellowship Program

This fellow will begin at the end of August 2024 and serve through August 2025. The deadline for applications is February 9, 2024. Recent graduates and AVMA member veterinarians are eligible to apply. Please visit AVMA’s 2023 – 2024 Fellowship Program website for more information. Any questions can be...

January 3, 2024

Federal Legislation Re: Scheduling of Xylazine

On December 12, 2023 the House passed the Support for Patients and Communities Reauthorization Act (SUPPORT Act), which contains key components of the AVMA-endorsed Combating Illicit Xylazine Act. The language within the SUPPORT Act would schedule xylazine as a Schedule III drug while exempting from scheduling the FDA-approved animal...

December 21, 2023